Evaluating the Feasibility of a Nurse-Driven Telephone Triage Intervention for Cancer Patients Undergoing Chemotherapy in the Ambulatory Setting
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Breast Carcinoma
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 90
- Locations
- 1
- Primary Endpoint
- Feasibility of completing nurse-driven telephone triage calls
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
This clinical trial studies how well a nurse-driven telephone intervention improves side effects in patients with cancer who are undergoing chemotherapy. Receiving calls from a nurse at home while receiving chemotherapy may improve the management of side effects and overall care in cancer patients.
Detailed Description
PRIMARY OBJECTIVES: I. To explore the feasibility of a proactive nurse-driven telephone triage intervention for patients with cancer receiving first-line chemotherapy in the ambulatory setting. SECONDARY OBJECTIVES: I. To explore the symptom experience of patients receiving a nurse-driven telephone triage intervention while receiving chemotherapy in the ambulatory setting. II. To explore the satisfaction of patients receiving a nurse-driven telephone triage intervention while receiving chemotherapy in the ambulatory setting. III. To explore the frequency of emergency room visits and hospital admissions for symptom management by patients receiving a nurse-driven telephone triage intervention while receiving chemotherapy in the ambulatory setting. OUTLINE: During standard of care chemotherapy, patients receive up to 18 telephone calls from a nurse using a standardized triage call script over 20 minutes.
Investigators
Eligibility Criteria
Inclusion Criteria
- •English speaking
- •Newly diagnosed patients with a breast, sarcoma, or head and neck cancer diagnosis preparing to undergo first-line, standard of care chemotherapy (patients with head and neck cancer may be undergoing concurrent first-line chemotherapy and radiation treatment)
- •All chemotherapy treatment to be completed at the study institution
Exclusion Criteria
- •Patients who have received previous chemotherapy treatment for cancer
- •Patients who will be receiving chemotherapy on research protocols
- •Pregnant patients, as they may be on unique treatment protocols outside standard of care or have symptom needs that are beyond the scope of this intervention
- •Patients who are unable to verbalize (e.g. due to tracheostomy)
Outcomes
Primary Outcomes
Feasibility of completing nurse-driven telephone triage calls
Time Frame: Up to 25 weeks
Completion is defined as the patient answering the call and completing the assessment; the target completion rate is set as 70%. Completion of nurse-driven calls will be assessed separately by center (breast, sarcoma, head and neck) and globally across all centers. The study will declare the intervention to be feasible within a center if the 90% confidence interval for completion rate is completely above 70% or contains 70%. To calculate the confidence interval, the study will construct a generalized linear mixed model with only a term for intercept.
Secondary Outcomes
- Patient Satisfaction(Up to 25 weeks)
- Number of emergency room visits(Up to 25 weeks)
- Number of hospital admissions(Up to 25 weeks)
- Symptom experience(Up to 25 weeks)